DRC11L
gene geneOn this page
Also known as TCAG_9762
Summary
DRC11L (dynein regulatory complex subunit 11 like, HGNC:22831) is a protein-coding gene on chromosome 7q36.1, encoding Dynein regulatory complex subunit like-11 (A6NCM1).
Predicted to enable ATP hydrolysis activity and microtubule severing ATPase activity. Predicted to be involved in microtubule cytoskeleton organization.
Source: NCBI Gene 392843 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 1 total
- MANE Select transcript:
NM_001304419
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:22831 |
| Approved symbol | DRC11L |
| Name | dynein regulatory complex subunit 11 like |
| Location | 7q36.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TCAG_9762 |
| Ensembl gene | ENSG00000278685 |
| Ensembl biotype | protein_coding |
| Entrez | 392843 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 nonsense_mediated_decay, 1 protein_coding
ENST00000611102, ENST00000613681, ENST00000615129
RefSeq mRNA: 1 — MANE Select: NM_001304419
NM_001304419
CCDS: CCDS78288
Canonical transcript exons
ENST00000615129 — 19 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001602946 | 151205444 | 151205496 |
| ENSE00001775321 | 151204509 | 151204836 |
| ENSE00003227856 | 151203395 | 151203514 |
| ENSE00003715064 | 151193291 | 151193490 |
| ENSE00003715120 | 151200383 | 151200454 |
| ENSE00003715891 | 151195575 | 151195658 |
| ENSE00003720034 | 151202911 | 151203096 |
| ENSE00003720841 | 151192743 | 151192829 |
| ENSE00003722459 | 151190873 | 151191087 |
| ENSE00003723255 | 151192276 | 151192453 |
| ENSE00003724583 | 151196448 | 151196554 |
| ENSE00003727457 | 151195430 | 151195485 |
| ENSE00003728912 | 151196977 | 151197052 |
| ENSE00003730627 | 151194256 | 151194363 |
| ENSE00003731810 | 151198798 | 151199003 |
| ENSE00003734945 | 151197205 | 151197327 |
| ENSE00003739402 | 151194516 | 151194598 |
| ENSE00003740583 | 151191638 | 151191876 |
| ENSE00003749559 | 151197822 | 151197906 |
Expression profiles
Bgee: expression breadth broad, 54 present calls, max score 82.58.
Top tissues by expression
99 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.58 | silver quality |
| left testis | UBERON:0004533 | 76.90 | gold quality |
| right testis | UBERON:0004534 | 76.37 | gold quality |
| testis | UBERON:0000473 | 76.02 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 68.80 | gold quality |
| sural nerve | UBERON:0015488 | 55.91 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 52.64 | gold quality |
| muscle of leg | UBERON:0001383 | 50.30 | gold quality |
| gastrocnemius | UBERON:0001388 | 49.62 | gold quality |
| muscle tissue | UBERON:0002385 | 47.44 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 45.45 | gold quality |
| right coronary artery | UBERON:0001625 | 43.76 | gold quality |
| bone marrow cell | CL:0002092 | 41.72 | gold quality |
| ganglionic eminence | UBERON:0004023 | 40.59 | gold quality |
| popliteal artery | UBERON:0002250 | 38.89 | silver quality |
| tibial artery | UBERON:0007610 | 38.86 | silver quality |
| ascending aorta | UBERON:0001496 | 38.42 | gold quality |
| thoracic aorta | UBERON:0001515 | 38.22 | silver quality |
| left uterine tube | UBERON:0001303 | 38.19 | silver quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| omental fat pad | UBERON:0010414 | 36.89 | gold quality |
| mucosa of stomach | UBERON:0001199 | 36.74 | silver quality |
| adipose tissue | UBERON:0001013 | 36.58 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 36.31 | silver quality |
| granulocyte | CL:0000094 | 36.11 | gold quality |
| right ovary | UBERON:0002118 | 35.81 | silver quality |
| prefrontal cortex | UBERON:0000451 | 35.78 | gold quality |
| tibial nerve | UBERON:0001323 | 35.68 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.11 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
5 targeting DRC11L, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3187-5P | 98.36 | 65.74 | 1776 |
| HSA-MIR-1285-3P | 97.72 | 67.02 | 1932 |
| HSA-MIR-5189-5P | 97.72 | 66.96 | 1814 |
| HSA-MIR-612 | 97.26 | 65.95 | 1597 |
| HSA-MIR-6860 | 97.21 | 66.31 | 1656 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Iqca1l | ENSMUSG00000038199 |
| rattus_norvegicus | Iqca1l | ENSRNOG00000011092 |
| drosophila_melanogaster | CG14183 | FBGN0036931 |
| drosophila_melanogaster | CG16789 | FBGN0037712 |
Paralogs (1): IQCA1 (ENSG00000132321)
Protein
Protein identifiers
Dynein regulatory complex subunit like-11 — A6NCM1 (reviewed: A6NCM1)
Alternative names: IQ and AAA domain-containing protein 1 pseudogene 1, IQ and AAA domain-containing protein 1-like
All UniProt accessions (3): A6NCM1, A0A087WVA7, A0A087X1I9
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the AAA ATPase family.
RefSeq proteins (1): NP_001291348* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000048 | IQ_motif_EF-hand-BS | Binding_site |
| IPR003959 | ATPase_AAA_core | Domain |
| IPR027417 | P-loop_NTPase | Homologous_superfamily |
| IPR052267 | N-DRC_Component | Family |
Pfam: PF00004, PF00612
UniProt features (8 total): region of interest 3, compositionally biased region 2, chain 1, domain 1, binding site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NCM1-F1 | 81.58 | 0.41 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (1): 567–574
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 16 (showing top):
GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ACID_ANHYDRIDES, GOMF_MICROTUBULE_SEVERING_ATPASE_ACTIVITY, GOMF_ATP_HYDROLYSIS_ACTIVITY, GOMF_ADENYL_NUCLEOTIDE_BINDING, GOMF_ISOMERASE_ACTIVITY, MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED, GOBP_MICROTUBULE_CYTOSKELETON_ORGANIZATION, GOBP_MICROTUBULE_SEVERING, GOMF_ATP_DEPENDENT_ACTIVITY, GOMF_PROTEIN_CONTAINING_COMPLEX_DESTABILIZING_ACTIVITY, GOBP_MICROTUBULE_BASED_PROCESS, GOMF_MACROMOLECULAR_CONFORMATION_ISOMERASE_ACTIVITY, GOMF_POLYPEPTIDE_CONFORMATION_OR_ASSEMBLY_ISOMERASE_ACTIVITY, GOMF_PURINE_NUCLEOTIDE_BINDING, GOBP_CYTOSKELETON_ORGANIZATION
GO Biological Process (1): microtubule severing (GO:0051013)
GO Molecular Function (5): ATP binding (GO:0005524), microtubule severing ATPase activity (GO:0008568), ATP hydrolysis activity (GO:0016887), nucleotide binding (GO:0000166), protein binding (GO:0005515)
GO Cellular Component (2): nucleus (GO:0005634), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| microtubule cytoskeleton organization | 2 |
| ATP-dependent activity | 2 |
| adenyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| polypeptide conformation or assembly isomerase activity | 1 |
| catalytic activity, acting on a protein | 1 |
| microtubule destabilizing activity | 1 |
| ribonucleoside triphosphate phosphatase activity | 1 |
| nucleoside phosphate binding | 1 |
| heterocyclic compound binding | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1323 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DRC11L | ENTREP2 | O60320 | 606 |
| DRC11L | C7orf33 | Q8WU49 | 570 |
| DRC11L | GBX1 | Q14549 | 543 |
| DRC11L | A0A087WTJ2 | A0A087WTJ2 | 511 |
| DRC11L | RNF212 | Q495C1 | 508 |
| DRC11L | ZNF425 | Q6IV72 | 481 |
| DRC11L | ZBED10P | Q96FA7 | 480 |
| DRC11L | ASB10 | Q8WXI3 | 480 |
| DRC11L | ZNF786 | Q8N393 | 479 |
| DRC11L | LRRC61 | Q9BV99 | 476 |
| DRC11L | LRRC14B | A6NHZ5 | 475 |
| DRC11L | ZNF783 | Q6ZMS7 | 475 |
| DRC11L | WDR86 | Q86TI4 | 469 |
| DRC11L | KRABD3 | A5PL33 | 448 |
| DRC11L | ZNF775 | Q96BV0 | 445 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| IQCA1L | RPL4 | psi-mi:“MI:0915”(physical association) | 0.400 |
| IQCA1L | H1-5 | psi-mi:“MI:0915”(physical association) | 0.400 |
ESM2 similar proteins: A0AVI2, A0FGR9, A3KGK3, A6NCM1, A6QQP7, B0DOB4, B3DLH6, B7FF09, B7ZC32, D3ZGS3, F1S5L4, O00329, O35904, O70145, O75923, P0DM40, P32019, P58069, P97564, Q0VA04, Q15283, Q17I16, Q1LXZ7, Q2WGJ9, Q32PH0, Q5DTI8, Q5GJ77, Q5RE88, Q5T0N1, Q5XIZ9, Q61586, Q62240, Q63713, Q69ZN7, Q6DCF6, Q6P5U7, Q6PA97, Q86VS3, Q86YR7, Q8BWR4
Diamond homologs: A2VDN5, A6H690, A6NCM1, A8IHT2, A8QFF6, A8XV40, B2RYN7, B3M301, B3P8A3, B4G437, B4HGG6, B4JII0, B4K799, B4M0H8, B4NBP4, B4PL32, B4QSF0, B7PXE3, O60058, P40328, Q298L4, Q5HY92, Q5ZK92, Q6AXQ7, Q6AZT2, Q719N1, Q7QBW0, Q86XH1, Q8I0P1, Q9CUL5, Q9ERZ6, Q9QYY8, Q9UBP0, Q6NW58, Q05AS3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3981 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:151191632:CCTCA:C | donor_loss | 1.0000 |
| 7:151191633:CTCAC:C | donor_loss | 1.0000 |
| 7:151191636:ACCT:A | donor_loss | 1.0000 |
| 7:151191637:CCTTC:C | donor_loss | 1.0000 |
| 7:151191658:C:A | donor_gain | 1.0000 |
| 7:151191875:CA:C | acceptor_gain | 1.0000 |
| 7:151191885:A:C | acceptor_gain | 1.0000 |
| 7:151192454:C:CC | acceptor_gain | 1.0000 |
| 7:151192460:C:CT | acceptor_gain | 1.0000 |
| 7:151192461:A:T | acceptor_gain | 1.0000 |
| 7:151192736:C:CA | donor_gain | 1.0000 |
| 7:151192737:CCTCA:C | donor_loss | 1.0000 |
| 7:151192738:CTCAC:C | donor_loss | 1.0000 |
| 7:151192740:CA:C | donor_loss | 1.0000 |
| 7:151192741:ACCT:A | donor_gain | 1.0000 |
| 7:151192742:CCT:C | donor_gain | 1.0000 |
| 7:151192742:CCTC:C | donor_gain | 1.0000 |
| 7:151192744:T:TA | donor_gain | 1.0000 |
| 7:151192826:CTAC:C | acceptor_gain | 1.0000 |
| 7:151192827:TAC:T | acceptor_gain | 1.0000 |
| 7:151192830:C:CC | acceptor_gain | 1.0000 |
| 7:151192830:CTGG:C | acceptor_loss | 1.0000 |
| 7:151192831:T:C | acceptor_loss | 1.0000 |
| 7:151192834:A:AC | acceptor_gain | 1.0000 |
| 7:151192834:A:C | acceptor_gain | 1.0000 |
| 7:151192840:C:CT | acceptor_gain | 1.0000 |
| 7:151192841:A:T | acceptor_gain | 1.0000 |
| 7:151193326:T:TA | donor_gain | 1.0000 |
| 7:151195569:T:C | donor_gain | 1.0000 |
| 7:151195600:T:TA | donor_gain | 1.0000 |
AlphaMissense
5332 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:151191871:A:G | W706R | 0.990 |
| 7:151191871:A:T | W706R | 0.990 |
| 7:151192375:C:A | G671W | 0.988 |
| 7:151193445:A:G | L564P | 0.987 |
| 7:151192374:C:T | G671E | 0.983 |
| 7:151192825:G:T | A617D | 0.982 |
| 7:151192804:A:T | V624E | 0.980 |
| 7:151196455:C:G | R436P | 0.980 |
| 7:151191084:A:G | W785R | 0.978 |
| 7:151191084:A:T | W785R | 0.978 |
| 7:151195633:A:G | L447P | 0.978 |
| 7:151204588:A:G | L87P | 0.978 |
| 7:151193406:A:T | V577D | 0.977 |
| 7:151191799:A:G | S730P | 0.976 |
| 7:151192281:C:G | R702P | 0.974 |
| 7:151192773:G:C | F634L | 0.974 |
| 7:151192773:G:T | F634L | 0.974 |
| 7:151192775:A:G | F634L | 0.974 |
| 7:151193380:C:G | A586P | 0.974 |
| 7:151193401:C:G | A579P | 0.974 |
| 7:151198819:C:G | R301P | 0.974 |
| 7:151197888:G:C | F314L | 0.973 |
| 7:151197888:G:T | F314L | 0.973 |
| 7:151197890:A:G | F314L | 0.973 |
| 7:151198814:A:G | W303R | 0.973 |
| 7:151198814:A:T | W303R | 0.973 |
| 7:151204600:C:G | R83P | 0.973 |
| 7:151192425:A:G | L654P | 0.972 |
| 7:151192826:C:G | A617P | 0.972 |
| 7:151192801:A:T | I625N | 0.971 |
dbSNP variants (sampled 300 via entrez): RS1000368595 (7:151205940 G>C), RS1000468077 (7:151193666 C>G,T), RS1000615188 (7:151202653 A>G), RS1000641011 (7:151200113 T>C), RS1000682003 (7:151203929 G>A), RS1000692874 (7:151195528 G>A,C), RS1000753923 (7:151190411 A>G), RS1001166174 (7:151199295 C>G,T), RS1001243785 (7:151194261 C>T), RS1001245913 (7:151199117 C>T), RS1001344508 (7:151204924 C>T), RS1001375598 (7:151204685 G>A,C), RS1001523384 (7:151197203 AC>A), RS1001694827 (7:151194776 G>C), RS1001694848 (7:151194465 C>A,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST012256_5 | SAPHO syndrome | 4.000000e-09 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
1 total (human), top 1 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): SAPHO syndrome